Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhangpi Ointment (also known as Zigui Zhangpi Ointment) is a topical traditional Chinese medicine (TCM) compound developed by the Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. It is formulated as an ointment comprising six botanical drugs (including *Glycyrrhiza uralensis* Fisch, *Angelica sinensis* (Oliv.) Diels, *Arnebia euchroma* (Royle) Johnst., *Rheum officinale* Baill, *Rehmannia glutinosa* Libosch, and *Cortex Lycii*) and two minerals (rubber powder and calomel). Zhangpi Ointment is primarily developed for the treatment of refractory wounds and skin ulcers, specifically hydroxyurea-induced leg ulcers in patients with myeloproliferative neoplasms. It promotes wound healing and re-epithelialization, potentially by modulating inflammatory mediators and upregulating vascular endothelial growth factor (VEGF) expression in wound tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhangpi Ointment.